Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors
NCT ID: NCT03319342
Last Updated: 2020-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
133 participants
INTERVENTIONAL
2017-07-11
2019-12-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)
NCT03025139
The Impact of Mindful Compassion on Sexual Functioning Post Breast Cancer Treatment
NCT06046716
A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors
NCT01558258
Mindful-life: Mindfulness Based Intervention vs Cognitive Behavioral Therapy in Patients With Breast Cancer
NCT03972020
The Effect of Self-compassion on Breast Cancer
NCT05240937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To refine two interventions - loving kindness and acts of kindness- for use with breast cancer survivors using an online platform.
II. To determine the feasibility and preliminary efficacy of these interventions on positive affect, depressive symptoms, and other aspects of well-being among women with breast cancer.
OUTLINE: Participants are randomized to 1 of 4 groups.
GROUP I (ACTS OF KINDNESS TO OTHERS): Participants perform small acts of kindness or generosity for others 3 times per week for 4 weeks and complete weekly online questionnaires.
GROUP II (ACTS OF KINDNESS TO SELF): Participants perform small acts of kindness for themselves 3 times per week for 4 weeks and complete weekly online questionnaires.
GROUP III (SELF-KINDNESS MEDITATION): Participants direct kind, loving thoughts to themselves, via guided meditation, 3 times per week for 4 weeks and complete weekly online questionnaires.
GROUP IV (CONTROL): Participants keep track of their daily activities, focusing on factual information rather than thoughts and feelings, on 3 separate days each week. At the end of the week, participants report on their activities and complete several online questionnaires.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (acts of kindness to others)
Participants perform small acts of kindness or generosity for others 3 times per week for 4 weeks and complete weekly online questionnaires.
Behavioral Intervention
Perform acts of kindness to others
Questionnaire Administration
Ancillary studies
Group II (acts of kindness to self)
Participants perform small acts of kindness for themselves 3 times per week for 4 weeks and complete weekly online questionnaires.
Behavioral Intervention
Perform acts of kindness to self
Questionnaire Administration
Ancillary studies
Group III (self-kindness meditation)
Participants direct kind, loving thoughts to themselves, via guided meditation, 3 times per week for 4 weeks and complete weekly online questionnaires.
Behavioral Intervention
Perform self-kindness meditation
Questionnaire Administration
Ancillary studies
Group IV (track daily activities)
Participants keep track of their daily activities, focusing on factual information rather than thoughts and feelings, on 3 separate days each week. At the end of the week, participants report on their activities and complete several online questionnaires.
Behavioral Intervention
Keep track of daily activities
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Intervention
Perform acts of kindness to others
Behavioral Intervention
Perform acts of kindness to self
Behavioral Intervention
Perform self-kindness meditation
Behavioral Intervention
Keep track of daily activities
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have completed treatment with surgery, radiation, and/or chemotherapy
* Have not had a cancer recurrence
* Have access to the internet and an active email account
19 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jonsson Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julienne Bower
Role: PRINCIPAL_INVESTIGATOR
UCLA / Jonsson Comprehensive Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
University of California-Riverside
Riverside, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2017-01469
Identifier Type: REGISTRY
Identifier Source: secondary_id
JCCCID776
Identifier Type: -
Identifier Source: secondary_id
17-000560
Identifier Type: OTHER
Identifier Source: secondary_id
17-000560
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.